-
公开(公告)号:US10172948B2
公开(公告)日:2019-01-08
申请号:US14551187
申请日:2014-11-24
申请人: Qi-Ying Hu , Hidetomo Imase
发明人: Qi-Ying Hu , Hidetomo Imase
IPC分类号: A61K38/00 , A61K47/48 , C07K1/113 , C07K7/64 , A61K47/54 , A61K47/62 , A61K47/64 , A61K47/68
摘要: The invention provides improved methods to prepare protein conjugates from a ketone-modified protein. In one embodiment, the protein is prepared by linking two free cysteines by reaction with a 1,3-dihaloacetone or similar ketone-containing reactant, linking the sulfur atoms of the two cysteines together. The ketone inserted between the sulfur atoms is then used to form an oxime, thus conjugating the protein to a payload. In another embodiment, two cysteine residues are tied together by reaction with a 1,3-dihaloacetone or similar reactant, and the new ketone is used to form an oxime with a suitable payload molecule, thus conjugating the protein to a payload. The method provides improved reaction conditions for the oxime formation, whereby higher yields and improved product homogeneity are achieved.
-
公开(公告)号:US20150150998A1
公开(公告)日:2015-06-04
申请号:US14551187
申请日:2014-11-24
申请人: Qi-Ying Hu , Hidetomo Imase
发明人: Qi-Ying Hu , Hidetomo Imase
CPC分类号: C07K7/64 , A61K47/542 , A61K47/62 , A61K47/646 , A61K47/68 , A61K47/6803 , A61K47/6849 , C07K1/1133 , C07K2317/40
摘要: The invention provides improved methods to prepare protein conjugates from a ketone-modified protein. In one embodiment, the protein is prepared by linking two free cysteines by reaction with a 1,3-dihaloacetone or similar ketone-containing reactant, linking the sulfur atoms of the two cysteines together. The ketone inserted between the sulfur atoms is then used to form an oxime, thus conjugating the protein to a payload. In another embodiment, two cysteine residues are tied together by reaction with a 1,3-dihaloacetone or similar reactant, and the new ketone is used to form an oxime with a suitable payload molecule, thus conjugating the protein to a payload. The method provides improved reaction conditions for the oxime formation, whereby higher yields and improved product homogeneity are achieved.
摘要翻译: 本发明提供了从酮修饰的蛋白质制备蛋白质缀合物的改进方法。 在一个实施方案中,通过与1,3-二卤代丙酮或类似的含酮反应物反应连接两个游离半胱氨酸来制备蛋白质,其将两个半胱氨酸的硫原子连接在一起。 然后将插入硫原子之间的酮用于形成肟,从而使蛋白质与有效载荷共轭。 在另一个实施方案中,通过与1,3-二卤代丙酮或类似反应物反应将两个半胱氨酸残基连接在一起,并且新的酮用于形成具有合适有效载荷分子的肟,从而将蛋白质与有效载荷共轭。 该方法为肟形成提供改进的反应条件,从而获得更高的产率和改善的产物均匀性。
-
公开(公告)号:US20130196899A1
公开(公告)日:2013-08-01
申请号:US13747621
申请日:2013-01-23
申请人: Frédéric ZECRI , Andrei GOLOSOV , Philipp GROSCHE , Kayo YASOSHIMA , Hongjuan ZHAO , Qi-Ying HU , Hidetomo IMASE , David Thomas PARKER
发明人: Frédéric ZECRI , Andrei GOLOSOV , Philipp GROSCHE , Kayo YASOSHIMA , Hongjuan ZHAO , Qi-Ying HU , Hidetomo IMASE , David Thomas PARKER
CPC分类号: A61M16/0816 , A61K38/00 , A61K38/10 , A61M16/0066 , A61M16/201 , A61M2016/0027 , A61M2016/003 , A61M2205/35 , A61M2205/502 , C07K7/08 , C07K7/56 , C07K7/60
摘要: The invention provides a synthetic polypeptide of Formula I′: or an amide, an ester or a salt thereof, wherein X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, X12 and X13 are defined herein. The polypeptides are agonist of the APJ receptor. The invention also relates to a method for manufacturing the polypeptides of the invention, and its therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译: 本发明提供式I'的合成多肽:或其酰胺,酯或其盐,其中X1,X2,X3,X4,X5,X6,X7,X8,X9,X10,X11,X12和X13被定义 这里。 多肽是APJ受体的激动剂。 本发明还涉及制备本发明多肽的方法及其治疗用途,例如治疗或预防急性失代偿性心力衰竭(ADHF),慢性心力衰竭,肺动脉高压,心房颤动,Brugada综合征,室性心动过速,动脉粥样硬化 ,高血压,再狭窄,缺血性心血管疾病,心肌病,心脏纤维化,心律失常,保水,糖尿病(包括妊娠糖尿病),肥胖,外周动脉疾病,脑血管意外,短暂性脑缺血发作,创伤性脑损伤,肌萎缩性侧索硬化,烧伤( 包括晒伤)和先兆子痫。 本发明还提供药理活性剂和药物组合物的组合。
-
公开(公告)号:US20120316195A1
公开(公告)日:2012-12-13
申请号:US13509646
申请日:2010-11-16
申请人: Martin Allan , Sylvie Chamoin , Qi-Ying Hu , Hidetomo Imase , Julien Papillon
发明人: Martin Allan , Sylvie Chamoin , Qi-Ying Hu , Hidetomo Imase , Julien Papillon
IPC分类号: A61K31/4418 , A61K31/4427 , A61K31/443 , A61K31/4439 , C07D491/048 , C07D401/04 , C07D409/04 , C07D405/04 , C07D213/57 , C07D213/30 , A61P9/06 , A61K31/4436 , C07D213/32 , A61P7/10 , A61P3/10 , A61P3/04 , A61P9/12 , A61P13/12 , A61P9/10 , A61P9/00 , A61P1/16 , A61P25/00 , A61P9/04 , A61P25/06 , A61K31/4355
CPC分类号: C07D213/57 , C07D213/30 , C07D213/61 , C07D401/04 , C07D405/04 , C07D409/04
摘要: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5 and n are defined herein. The invention also relates to a method for manufacturing compounds of the invention, and their therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译: 本发明提供式(I)化合物或其药学上可接受的盐,其中R 1,R 2,R 3,R 4,R 5和n如本文所定义。 本发明还涉及一种制备本发明化合物的方法及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
公开(公告)号:US20120225874A1
公开(公告)日:2012-09-06
申请号:US13473649
申请日:2012-05-17
申请人: Masashi KISHIDA , Naoko MATSUURA , Hidetomo IMASE , Yuki IWAKI , Ichiro UMEMURA , Osamu OHMORI , Eiji KAWAHARA
发明人: Masashi KISHIDA , Naoko MATSUURA , Hidetomo IMASE , Yuki IWAKI , Ichiro UMEMURA , Osamu OHMORI , Eiji KAWAHARA
IPC分类号: A61K31/4709 , C07D405/14 , C07D401/14 , C07D413/14 , A61K31/5377 , A61K31/506 , C07D403/12 , A61K31/498 , C07D471/04 , A61K31/437 , A61P7/10 , A61P3/06 , A61P9/10 , A61P9/00 , A61P3/00 , A61P7/02 , A61P9/12 , A61P9/04 , A61P3/10 , C07D401/12
CPC分类号: C07D471/04 , C07D401/12 , C07D401/14
摘要: The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.
摘要翻译: 本发明涉及新的式(I)化合物或其药物组合物,其全部变量在本文中定义。 本发明还涉及本文中的化合物用于治疗或延缓进展到涉及CETP的疾病的公开。
-
公开(公告)号:US20150252076A1
公开(公告)日:2015-09-10
申请号:US14714914
申请日:2015-05-18
申请人: Frederic ZECRI , Andrei GOLOSOV , Philipp GROSCHE , Hongjuan ZHAO , Qi-Ying HU , Hidetomo IMASE
发明人: Frederic ZECRI , Andrei GOLOSOV , Philipp GROSCHE , Hongjuan ZHAO , Qi-Ying HU , Hidetomo IMASE
CPC分类号: A61M16/0816 , A61K38/00 , A61K38/10 , A61M16/0066 , A61M16/201 , A61M2016/0027 , A61M2016/003 , A61M2205/35 , A61M2205/502 , C07K7/08 , C07K7/56 , C07K7/60
摘要: The invention provides a synthetic polypeptide of Formula I′: or an amide, an ester or a salt thereof, wherein X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, X12 and X13 are defined herein. The polypeptides are agonist of the APJ receptor. The invention also relates to a method for manufacturing the polypeptides of the invention, and its therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译: 本发明提供式I'的合成多肽:或其酰胺,酯或其盐,其中X1,X2,X3,X4,X5,X6,X7,X8,X9,X10,X11,X12和X13被定义 这里。 多肽是APJ受体的激动剂。 本发明还涉及制备本发明多肽的方法及其治疗用途,例如治疗或预防急性失代偿性心力衰竭(ADHF),慢性心力衰竭,肺动脉高压,心房颤动,Brugada综合征,室性心动过速,动脉粥样硬化 ,高血压,再狭窄,缺血性心血管疾病,心肌病,心脏纤维化,心律失常,保水,糖尿病(包括妊娠糖尿病),肥胖,外周动脉疾病,脑血管意外,短暂性脑缺血发作,创伤性脑损伤,肌萎缩性侧索硬化,烧伤( 包括晒伤)和先兆子痫。 本发明还提供药理活性剂和药物组合物的组合。
-
公开(公告)号:US08759365B2
公开(公告)日:2014-06-24
申请号:US12745105
申请日:2008-12-01
申请人: Muneto Mogi , Toshio Kawanami , Ken Yamada , Kayo Yasoshima , Hidetomo Imase , Takahiro Miyake , Osamu Ohmori
发明人: Muneto Mogi , Toshio Kawanami , Ken Yamada , Kayo Yasoshima , Hidetomo Imase , Takahiro Miyake , Osamu Ohmori
IPC分类号: A61K31/5377 , A61K31/506 , A61K31/41 , A61K31/40 , C07D413/14 , C07D405/14 , C07D401/12 , C07D401/14 , C07D403/12 , C07D207/14
CPC分类号: C07D207/14 , C07D401/14 , C07D403/12 , C07D403/14 , C07D405/14 , C07D413/14
摘要: The present invention provides a compound of formula (I): wherein the variants R1, R2, R3, R4, R6, R7 are as defined herein, and wherein said compound is an inhibitor of CETP, and thus can be employed for the treatment of a disorder or disease mediated by CETP or responsive to the inhibition of CETP.
摘要翻译: 本发明提供式(I)化合物:其中变体R1,R2,R3,R4,R6,R7如本文所定义,并且其中所述化合物是CETP的抑制剂,因此可用于治疗 由CETP介导的疾病或疾病或响应于CETP的抑制。
-
8.
公开(公告)号:US20140142022A1
公开(公告)日:2014-05-22
申请号:US14165680
申请日:2014-01-28
申请人: Frederic ZECRI , Andrei GOLOSOV , Philipp GROSCHE , Kayo YASOSHIMA , Hongjuan ZHAO , Qi-Ying HU , Hidetomo IMASE , David Thomas PARKER
发明人: Frederic ZECRI , Andrei GOLOSOV , Philipp GROSCHE , Kayo YASOSHIMA , Hongjuan ZHAO , Qi-Ying HU , Hidetomo IMASE , David Thomas PARKER
IPC分类号: C07K7/08
CPC分类号: A61M16/0816 , A61K38/00 , A61K38/10 , A61M16/0066 , A61M16/201 , A61M2016/0027 , A61M2016/003 , A61M2205/35 , A61M2205/502 , C07K7/08 , C07K7/56 , C07K7/60
摘要: The invention provides a synthetic polypeptide of Formula I′: or an amide, an ester or a salt thereof, wherein X1, X2, X3, X4, X5, X6, X7, X8, X9, X10, X11, X12 and X13 are defined herein. The polypeptides are agonist of the APJ receptor. The invention also relates to a method for manufacturing the polypeptides of the invention, and its therapeutic uses such as treatment or prevention of acute decompensated heart failure (ADHF), chronic heart failure, pulmonary hypertension, atrial fibrillation, Brugada syndrome, ventricular tachycardia, atherosclerosis, hypertension, restenosis, ischemic cardiovascular diseases, cardiomyopathy, cardiac fibrosis, arrhythmia, water retention, diabetes (including gestational diabetes), obesity, peripheral arterial disease, cerebrovascular accidents, transient ischemic attacks, traumatic brain injuries, amyotrophic lateral sclerosis, burn injuries (including sunburn) and preeclampsia. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译: 本发明提供式I'的合成多肽:或其酰胺,酯或其盐,其中X1,X2,X3,X4,X5,X6,X7,X8,X9,X10,X11,X12和X13被定义 这里。 多肽是APJ受体的激动剂。 本发明还涉及制备本发明多肽的方法及其治疗用途,例如治疗或预防急性失代偿性心力衰竭(ADHF),慢性心力衰竭,肺动脉高压,心房颤动,Brugada综合征,室性心动过速,动脉粥样硬化 ,高血压,再狭窄,缺血性心血管疾病,心肌病,心脏纤维化,心律失常,保水,糖尿病(包括妊娠糖尿病),肥胖,外周动脉疾病,脑血管意外,短暂性脑缺血发作,创伤性脑损伤,肌萎缩性侧索硬化,烧伤( 包括晒伤)和先兆子痫。 本发明还提供药理活性剂和药物组合物的组合。
-
公开(公告)号:US08519134B2
公开(公告)日:2013-08-27
申请号:US13509646
申请日:2010-11-16
申请人: Martin Allan , Sylvie Chamoin , Qi-Ying Hu , Hidetomo Imase , Julien Papillon
发明人: Martin Allan , Sylvie Chamoin , Qi-Ying Hu , Hidetomo Imase , Julien Papillon
IPC分类号: C07D221/02 , A61K31/44
CPC分类号: C07D213/57 , C07D213/30 , C07D213/61 , C07D401/04 , C07D405/04 , C07D409/04
摘要: The present invention provides a compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5 and n are defined herein. The invention also relates to a method for manufacturing compounds of the invention, and their therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition.
摘要翻译: 本发明提供式(I)化合物或其药学上可接受的盐,其中R 1,R 2,R 3,R 4,R 5和n如本文所定义。 本发明还涉及一种制备本发明化合物的方法及其治疗用途。 本发明还提供药理活性剂和药物组合物的组合。
-
公开(公告)号:US08232403B2
公开(公告)日:2012-07-31
申请号:US12300208
申请日:2007-05-08
申请人: Masashi Kishida , Naoko Matsuura , Hidetomo Imase , Yuki Iwaki , Ichiro Umemura , Osamu Ohmori , Eiji Kawahara
发明人: Masashi Kishida , Naoko Matsuura , Hidetomo Imase , Yuki Iwaki , Ichiro Umemura , Osamu Ohmori , Eiji Kawahara
IPC分类号: A61K31/47 , C07D215/46
CPC分类号: C07D471/04 , C07D401/12 , C07D401/14
摘要: The present invention relates to novel compounds of formula (I) or a pharmaceutical composition thereof, with all the variables being defined in the text. The present invention further relates to the use of the compounds herein for treatment of or delay progression to overt to diseases in which CETP is involved.
摘要翻译: 本发明涉及新的式(I)化合物或其药物组合物,其全部变量在本文中定义。 本发明还涉及本文中的化合物用于治疗或延缓进展到涉及CETP的疾病的公开。
-
-
-
-
-
-
-
-
-